Company ProfilePremium

Macarthur Minerals Limited

Company Profile Analysis

Ticker: MIO.AX

ESOMAR 23 Corporate BadgeISO Certifications Badge
Macarthur Minerals Limited - Company showcase

Year Founded & Workforce

2002

2 Employees

Macarthur Minerals Limited logo

Macarthur Minerals Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Macarthur Minerals Limited Overview

Macarthur Minerals is a Brisbane-headquartered, ASX-listed iron ore development company. Its single core asset is the 100%-owned Lake Giles Iron Project in Western Australia's Yilgarn region, about 175 km north-west of Kalgoorlie. The project has two parts. The first is the large Moonshine magnetite resource: about 1.27 billion tonnes across all categories, supporting a 2022 Feasibility Study for a 3 Mtpa, 25-year operation producing 66% Fe concentrate. The second is the smaller Ularring hematite resource of about 80 Mt, which is permitted for development. In 2024 Macarthur stopped trying to develop Ularring itself. It sold the hematite mining rights to Gold Valley Yilgarn for A$750,000 cash plus up to A$10M in milestone royalties and a perpetual A$1/dmt royalty. Gold Valley assigned half of that position to mining contractor Destec in 2026. The company is now effectively a royalty-and-optionality vehicle. It has minimal cash, going-concern qualifications, and a magnetite asset that needs a strategic partner able to fund roughly A$863M of initial capital.


Company's own description. The FY2025 Annual Report states that Macarthur "has three iron ore projects in the Yilgarn region of Western Australia" and "two exploration project areas in the Pilbara, Western Australia targeting iron ore." Its principal activity is "mineral resource exploration and evaluation." The risk section is more candid: the group is "at an intermediate stage in its evolution as a Mining Evaluation and Investment company having sold the right to mine its Hematite Project to GVY in 2024," and exploration "is now minimal pending the realisation of the royalty income stream." Standard ASX releases still describe the company as "an iron ore development and lithium exploration company that is focused on bringing to production its Western Australia iron ore projects" (Quarterly Activities Report, 30 July 2026).

Independent characterisation. In practice, Macarthur is a pre-revenue holding company with four economic exposures:

  1. A contingent royalty stream. This comes from the Ularring/Treppo Grande hematite rights sold to Gold Valley Yilgarn (GVY), now held 50:50 by GVY and Destec. The royalty pays A$5M after the first 1 Mt dry metric tonnes sold, another A$5M after the second 1 Mt, then A$1/dmt thereafter. Macarthur keeps legal and beneficial title to the tenements.

  2. A long-dated, capital-heavy development option. This is the Moonshine magnetite project, which has a completed Feasibility Study but no financing partner.

  3. Early-stage exploration optionality. This covers nickel and cobalt at Lake Giles (historical intercepts and seven untested targets), non-iron-ore sampling that has so far been inconclusive, Pilbara iron-ore rights on two Infinity Mining-encumbered tenements, a Treppo Grande/Mount Manning licence application, and a dormant Nevada lithium subsidiary.

  4. Infrastructure positioning. This includes miscellaneous licences for haul roads and borefields, an earlier MOU with the Southern Ports Authority for Esperance access, and a dedicated export subsidiary, Esperance Iron Ore Export Company Pty Ltd.

Revenue model. There is currently no product, service, subscription or licensing revenue. Reported "revenue" consists of rental income, interest and sundry recoveries: A$46,578 in FY2025 and about A$13K trailing-twelve-month in FY2026 (Kalkine). The intended future model is a royalty model on hematite, plus a concentrate-sales model on magnetite. The magnetite model would sell 66% Fe concentrate to steelmakers via rail to Esperance. Macarthur previously held a binding life-of-mine offtake agreement with Glencore International, signed in March 2019 and reported at the time of the 2019 ASX IPO. Its current status is not publicly confirmed in 2025–2026 filings.

Value chain position. Upstream: exploration, evaluation and permitting. Macarthur has no mining, processing, logistics or marketing operations. Under the hematite agreement, GVY and Destec carry operating, funding and regulatory responsibility.

Customer types and end-markets. The target customers are integrated steelmakers, mainly in Asia, buying seaborne iron ore. High-grade magnetite concentrate is also positioned for lower-emission steelmaking such as pelletising, direct reduction and "green iron". The company brands itself "the green iron ore company" on its letterhead. There were no customers above 10% of revenue in FY2024 or FY2025 because there is no customer revenue (FY2025 AR, Note 4).

Strategy

Stated strategic themes (FY2025 AR Chairman's Letter; 2026 quarterlies):

  1. Unlock near-term revenue from the hematite assets through a third-party operator, using a royalty model in which the operator funds and manages "all operational and regulatory aspects."

  2. Keep 100% ownership of the Moonshine magnetite project, the long-term value driver, and secure "strategic transactions that can drive development" through Nigel Jones's network.

  3. Keep Lake Giles tenure "in good standing" with minimal cash spend.

  4. Simplify the corporate structure and cost base: TSXV/OTC delisting, Infinity divestment, office relocation and auditor change.

  5. Position the company within "green iron" narratives by using high-grade magnetite as feed for low-emission steelmaking.

ESG and sustainability commitments. Climate change is acknowledged as a risk. There are no quantified targets.

Cost programs. No formal program with targets, although cost containment is cited in the September 2025 Appendix 5B.

Medium-term financial targets and guidance. None issued. The FY2025 AR said the group "is dependent on the commencement of the royalty income stream commencing in the 2025/26 financial year." That did not happen in FY2026.

Products & Services

Macarthur has no commercial products or services. Its "portfolio" is a set of mineral assets and potential products. Each is catalogued below.

Moonshine Magnetite Concentrate (planned flagship product)

ItemAUD MnUSD Mn
Life-of-mine sales revenue12,6148,956
Life-of-mine operating expenses8,1165,672
Construction capex801.1568.8
Pre-strip61.643.8
Total initial capital862.7612.5
Sustaining capital203.0144.1
Total future capital598.0424.6
Closure and rehabilitation58.241.3
Total operating cash flow3,6252,574
Tax paid873620
Royalties631435
NPV (6%) pre-tax816579
NPV (6%) post-tax443314
IRR pre-tax13.0%—
IRR post-tax10.1%—

Description: High-grade magnetite concentrate from the Moonshine and Moonshine North deposits, Lake Giles.

  • Key specifications (2022 Feasibility Study, NI 43-101 filed 11 Apr 2022). Concentrate grade 66.1–66.2% Fe; SiO2 about 6.5%; Al2O3 about 0.1%; P about 0.02%; plant recovery 31% (DTR basis); throughput 3 Mtpa concentrate (dry); 74 Mt total concentrate over 25 years.

Reserves: 51.9 Mt Proven @ 30.6% Fe and 184.7 Mt Probable @ 27.6% Fe, totalling 236.6 Mt @ 28.2% Fe head grade, at a DTR cut-off above 15%.

Resources: 53.9 Mt Measured, 218.7 Mt Indicated and 997.0 Mt Inferred (Aug 2020).

Target customer: Seaborne steelmakers, blast-furnace pellet feed and DRI pathways.

Status: Feasibility complete; not financed; no offtake currently confirmed in 2025–26 filings. The 2019 Glencore agreement's status is not publicly disclosed.

Pricing model: Index-linked iron ore pricing, assumed in the Feasibility Study. Specific price assumptions are not restated in recent filings.

Feasibility Study economics (single-period, FY2022 study, A$ M unless stated):

Source: FY2025 AR, Table 1. Strip ratio 2.64; ore mined 236.6 Mt; waste 624.9 Mt.

Ularring Hematite (direct shipping ore) — now a royalty asset

Resource: 54.5 Mt @ 47.2% Fe Indicated and 26 Mt @ 45.4% Fe Inferred (CSA Global; NI 43-101 PFS, 2012).

Approvals: Environmental approvals under the WA Environmental Protection Act 1986 and the federal EPBC Act 1999. Program of Work approvals were received on 2 April 2026 (M30/249 and M30/213; clearing, access and ground disturbance) and announced 3 September 2026 (Central region hematite bulk sampling).

Commercial structure: Hematite mining rights over Ularring and Treppo Grande (excluding Moonshine) were sold to GVY in 2024. Consideration was A$750,000 cash (received in full by 17 Dec 2024), plus A$5M on the first 1 Mt dmt sold, A$5M on the second 1 Mt dmt, and A$1/dmt thereafter. Since 4 June 2026, GVY and Destec Contracting each hold 50% of the counterparty position.

Product intent: Bulk sampling to assess product quality, beneficiation response and blending with magnetite (Q1 FY2027 quarterly).

Treppo Grande / Mount Manning Iron Project

Area: 68 km² located 32 km west of Lake Giles, near rail to Esperance.

Status: E77/2521 refused on 16 Sep 2022. ELA 77/3186 (23 sub-blocks) has been under application since 22 Nov 2023 and is held by Esperance Iron Ore Export Company. It lies within the proposed Helena and Aurora Range National Park, which is a material permitting risk.

Lake Giles Nickel and Cobalt Targets

Evidence: 319 historical holes with ≥0.1% Ni and 150 holes with ≥0.2% Ni. Best intercept: LGDD_054, 23.5 m @ 0.85% Ni including 11.5 m @ 1.03% Ni. Gossanous grab samples assayed up to 2.61% Co and 2.01% Ni. Seven advanced targets remain untested (May 2023 release).

Status: Dormant. A non-iron-ore sampling program at Lake Giles returned initial results that were "inconclusive" (Jun-2026 quarterly).

Pilbara Iron-Ore Rights

Tenements: E45/4735 (Strelley Gorge, 5 sub-blocks, expires 20 Nov 2027) and E45/5324 (North Tambourah, 4 sub-blocks, expires 2029). Total area about 24 km².

Encumbrance: Infinity Mining holds non-iron-ore rights. Strelley Gorge borders the Sulphur Springs VHMS deposit owned by Develop Global.

Infrastructure Tenure (enabling assets)

  • Miscellaneous licences L30/71, L30/89 (23,663 ha, granted 11 Dec 2024), L30/92 (31,650 ha), L30/93, plus pending L15/409, L16/133, L30/90 and L30/91.

  • General-purpose leases G30/10–12 (pending).

  • E30/568 and E30/592 (3,277 ha, applied 25 Sep 2025).

  • Purpose: haul roads, borefields and water supply. These support any development route to the Perth–Kalgoorlie railway, about 90 km away.

Nevada Lithium

  • Held through Macarthur Lithium Nevada Limited. No activity has been reported in FY2025–FY2026 quarterlies. Asset details are not publicly disclosed in recent filings.

Financial Narrative

All figures are in A$ millions unless stated, for fiscal years ending 31 March. FY2022–FY2025 come from the audited FY2025 AR (five-year summary and primary statements).

Income Statement

Notes: - The FY2022 profit reflects non-operating gains, not sales. TipRanks reports FY2022 net income as A$4.38M versus A$4.45M in the AR. The AR figure is used.

  • FY2026 EBITDA (-A$1.536M) is Kalkine's trailing-twelve-month figure.

  • FY2026 net loss (A$1,822,189) is from the FY2026 AR as summarised by FilingReader.

  • StockAnalysis reports FY2026 trailing-twelve-month EPS of about -A$0.01.

Margins and growth. Gross, operating, EBITDA and net margins are not meaningful: there is no sales revenue, so the denominators are zero or immaterial. Revenue CAGR is likewise not meaningful.

Commentary. The earnings record has three distinct regimes:

FY2022 profit: A paper profit driven by non-operating gains around the Infinity Mining spin-out.

FY2023–FY2024 cash-burn phase: Losses of A$4.9M and A$5.8M. These were inflated by share-based compensation (A$1.15M in FY2024) and equity-accounted losses and impairment on Infinity (A$2.42M combined in FY2024).

FY2025 capitulation: The hematite sale crystallised a A$21.99M accounting loss, because carrying value was written down to the A$750K cash consideration. The contingent A$10M+ royalties were not recognised as an asset.

FY2026 is the first "clean" year. The net loss of A$1.82M reflects a lean corporate structure: two employees, board-led management and minimal exploration. Even so, the loss remains large relative to cash on hand.

Balance Sheet

Notes: - FY2026 equity is derived as total assets (A$53.885M) less total liabilities (A$1.507M), both per Kalkine.

  • FY2025 cash was just A$784 at 31 March 2025. This confirms the acute liquidity position before the May 2025 convertible note and the July 2025 rights issue.

  • FY2023 cash and equity come from the opening balances in the FY2024 statements.

Commentary. The balance sheet is almost entirely capitalised exploration and evaluation expenditure. That balance stood at A$52.5M at FY2025, against total assets of A$52.9M. The A$22.8M fall in FY2025 reflects the hematite sale write-down. Equity has held near A$51–52M since then. With market capitalisation at roughly A$7M, the market prices the company at about 0.13–0.14x book. That is a deep discount, consistent with doubts about both recoverability and funding. Debt has been small and mostly owed to directors and a major shareholder: director loans totalled A$134K at FY2025.

Cash Flow

Commentary. The September 2025 quarter outflow of A$1.76M likely included settlement of accumulated creditors and accrued director fees after the rights issue. Payables had reached A$1.54M at FY2025. In the March 2026 quarter, net operating outflow was only A$118K, helped by A$102K of receipts, which suggests a much-reduced run-rate. Cash still fell from A$799K to A$324K in the June 2026 quarter. That implies a quarterly burn of roughly A$0.45M once placement costs and accrued items are included. On those figures, the company has funding into roughly late calendar 2026 without new capital, so another raise is likely within months. This is an analyst inference.

Ratios

Ratios are computed by the analyst from the reported figures above. Net debt to EBITDA and interest coverage are not meaningful because EBITDA is negative. The cash conversion cycle does not apply to a company with no inventory or sales.

Going concern. Auditors flagged a material uncertainty over going concern in both FY2025 (RSM) and FY2026, per FilingReader. At FY2025, current liabilities exceeded current assets by A$1.50M.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Revenue by Segment and Revenue by Segment (%)

MetricFY2022FY2023FY2024FY2025FY2026

Exploration segment revenue and other income (AUD Mn)

9.1970.9030.2570.0470.013

Exploration segment pre-tax result (AUD Mn)

4.452-4.885-5.762-26.533-1.822

Share of total group revenue (%)

100100100100100

Group Entities

EntityOwnershipFunction

Macarthur Minerals Limited

Parent; ASX-listed

Holding company

Macarthur Australia Limited

100%

Intermediate holding company

Macarthur Iron Ore Pty Ltd ("MIO")

100% (via Macarthur Australia)

Holds Lake Giles and Pilbara iron-ore tenements; counterparty to the Lake Giles Hematite Agreement

Esperance Iron Ore Export Company Pty Ltd (formerly Macarthur Midway Pty Ltd)

100%

Export logistics vehicle; applicant for E77/3186 (Mount Manning)

Macarthur Lithium Nevada Limited

100%

Nevada lithium exploration (inactive in current disclosures)

Macarthur Marble Bar Lithium Pty Ltd (formerly Bachelor Project Pty Ltd)

100%

Dormant

Macarthur Minerals NT Pty Ltd and Macarthur Tulshyan Pty Ltd

100%

Northern Territory vehicles (inactive)

Asset group

Asset groupContentsStatus (Oct 2026)

Lake Giles – Moonshine Magnetite

Moonshine and Moonshine North deposits; 236.6 Mt Proven and Probable reserve

Feasibility Study complete (2022); seeking partner; no field work in recent quarters

Lake Giles – Ularring Hematite (and Treppo Grande)

54.5 Mt Indicated + 26 Mt Inferred hematite; environmentally approved

Mining rights sold to GVY (now GVY 50% / Destec 50%); Macarthur keeps title and royalties; bulk-sampling PoWs approved Apr and Sep 2026

Lake Giles – Nickel/Cobalt

Komatiite-hosted Ni targets; historical intercepts

Untested; non-iron sampling inconclusive

Pilbara iron ore

E45/4735 (Strelley Gorge), E45/5324 (North Tambourah)

Iron-ore rights only; Infinity Mining holds non-iron rights

Nevada lithium

Macarthur Lithium Nevada Ltd

Not mentioned in recent quarterly activities

Income Statement and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Revenue and other income (AUD Mn)

9.1970.9030.2590.0470.013

Of which operating sales revenue (AUD Mn)

00000

Gross profit (AUD Mn)

————0.013

EBITDA (AUD Mn)

4.489-4.793-5.627-26.435-1.536

EBIT / operating result (AUD Mn)

4.457-4.866-5.698-26.474—

Pre-tax income (AUD Mn)

4.452-4.885-5.762-26.533-1.822

Net income (AUD Mn)

4.452-4.885-5.762-26.533-1.822

Basic EPS (A$ cents)

3.10-2.97-3.47-13.92—

Diluted EPS (A$ cents)

3.10-2.97-3.47-13.92—

Dividends per share (A$ cents)

00000

Weighted average shares (M)

147.93164.64166.06190.60—

Expense line

Expense lineFY2024FY2025

Loss on sale of Hematite Project

021,990,791

Personnel costs

844,7711,160,162

Professional fees

661,298944,051

Net fair value loss on financial assets

0773,368

Loss on disposal of financial assets

0454,972

Impairment of exploration and evaluation

0309,524

Share registry, filing and listing fees

195,670209,044

Share-based compensation

1,149,201190,729

Office and general

294,423152,879

Share of associate losses (Infinity)

1,778,4310

Impairment of investment in associate

644,3150

Investor relations

277,42133,898

Total expenses

6,020,60826,579,503

Balance Sheet

MetricFY2022FY2023FY2024FY2025FY2026

Total assets (AUD Mn)

——77.69052.88853.885

Cash and equivalents (AUD Mn)

—1.9440.1810.0010.796

Exploration and evaluation assets (AUD Mn)

——75.29252.532—

Total current assets (AUD Mn)

——0.4180.293—

Short-term borrowings (AUD Mn)

——0.8380.244—

Long-term borrowings (AUD Mn)

——00—

Lease liabilities (AUD Mn)

——0.0810—

Total liabilities (AUD Mn)

——1.7411.8071.507

Net debt (AUD Mn)

——0.7380.243—

Total equity (AUD Mn)

—80.07675.95051.08252.378

Goodwill and intangibles (AUD Mn)

00000

Working capital (AUD Mn)

——-1.299-1.499—

Issued capital (AUD Mn)

—128.198128.615130.089—

Accumulated losses (AUD Mn)

—-58.708-64.469-90.214—

Cash Flow

MetricFY2022FY2023FY2024FY2025FY2026

Operating cash flow (AUD Mn)

——-1.745-1.331—

Exploration and evaluation payments (AUD Mn)

——-1.062-0.290—

Property, plant and equipment capex (AUD Mn)

——-0.001-0.019—

Free cash flow incl. E&E (AUD Mn)

——-2.808-1.640—

Proceeds from asset sales (AUD Mn)

——01.139—

Financing cash flow (AUD Mn)

——1.1240.320—

Dividends paid (AUD Mn)

00000

Buybacks (AUD Mn)

00000

Financial Analysis

MetricQ2 FY2026 (Sep-25)Q4 FY2026 (Mar-26)Q1 FY2027 (Jun-26)

Net operating cash flow

-1.760-0.118—

Net financing cash flow

2.2870.771—

Closing cash

0.3150.7990.324

Estimated quarters of funding

0.186.77—

Returns & Leverage Ratios (%) and Financial Ratios (x)

MetricFY2023FY2024FY2025FY2026

ROE on closing equity (%)

-6.1-7.6-51.9-3.5

ROA on closing assets (%)

—-7.4-50.2-3.4

Current ratio (x)

—0.240.16—

Debt to equity (x)

—0.0110.005—

Asset turnover (x)

—0.0030.0010.000

Revenue by Region

RegionFY2024FY2025FY2026

Australia revenue and other income (AUD Mn)

0.2590.0470.013

United States revenue (AUD Mn)

000

Rest of world revenue (AUD Mn)

000

Share Price

MetricFY2021FY2022FY2023FY2024FY2025FY2026

Share price at fiscal year end (CAD, TSXV)

0.510.470.150.090.03—

Share price at or near fiscal year end (A$, ASX)

—————0.026

Valuation Multiples

MultipleMIOComment

P/B

about 0.14x

About A$7.1M market cap (Kalkine) against about A$52.4M equity (FY2026)

EV per reserve tonne

about A$0.03/t

About A$7M EV against 236.6 Mt reserve (analyst-calculated)

Share Price & Returns

DateInstrumentSizePrice (AUD)Attaching securities

Dec 2019

ASX IPO

20,032,952 shares / A$5.008M

0.25—

Apr 2022

Placement

A$5.72M net

——

Mar 2024

Rights offering

A$580,760

—

Options at A$0.28, expired 27 Sep 2025

Jul 2024

Placement

24,193,831 shares / A$1.282M

0.053

12,096,915 options at A$0.10, expired 29 Jul 2026

May 2025

Convertible notes

A$250K

Convert at 0.015

—

Jul 2025

Renounceable rights issue (1-for-2)

About A$1.996M

0.02

1 option per 2 shares, A$0.03, 2-year term

Apr 2026

Placement

50,000,000 shares / A$1.25M

0.025

25,000,000 options at A$0.05, expire 7 Oct 2027

Analyst Conclusions

Management guidance. None quantitative. Management's stated priorities are:

  • keeping Lake Giles tenure in good standing;

  • advancing bulk sampling with GVY and Destec;

  • assessing development, funding and strategic pathways for Moonshine; and

  • managing working capital carefully (Jun-2026 quarterly).

Consensus. There is no analyst coverage, so no consensus growth expectations exist.

Bull Case

  1. Royalty asymmetry. If GVY and Destec move from bulk sampling to shipments of about 1 Mt, a A$5M payment would arrive at no cost to Macarthur. That is roughly 70% of the current market cap. A second A$5M follows at 2 Mt. Destec's arrival as both operator partner and shareholder improves the odds of execution compared with GVY alone.

  2. Deep asset discount. The market values a 236.6 Mt reserve with a completed Feasibility Study (post-tax NPV6 A$443M in 2022 terms) at about A$7M, or about 0.14x book. Any credible strategic partner would revalue the equity materially.

  3. Green-iron tailwind. High-grade (66% Fe), low-impurity concentrate fits DR and pellet feed, where premiums are widening. A director with Simandou experience makes a partnership narrative more credible than for typical juniors.

Bear Case

  1. Funding death spiral. Cash was A$324K at June 2026, against roughly A$0.45M quarterly outflow, with going-concern qualifications two years running. Macarthur will likely need to raise money again soon at or below A$0.02, extending serial dilution of 50% or more per year.

  2. Royalty slippage. The FY2025 AR expected royalties to start in FY2025/26. None have been reported. Activity has stayed at the PoW and sampling stage, and low-grade (about 45–47% Fe) in-situ hematite may not be economic without beneficiation.

  3. Magnetite unfinanceable as specified. A 10.1% post-tax IRR, 31% recovery and A$863M initial capital (2022 dollars, before cost inflation) make the project marginal. Western Australian magnetite history makes lenders cautious, and new high-grade Simandou supply competes in the same premium niche.

Key Catalysts and Monitorables (next 12 months)

CatalystExpected timingWatch for
Bulk-sampling execution by GVY and DestecQ4 2026–H1 2027On-ground start, tonnages, beneficiation results
Next capital raisingNear term (implied by cash)Price, size, strategic participation by Destec, GVY or Copulos
Sep-2026 and Dec-2026 quarterlies and Appendix 5Bs31 Oct 2026; Jan 2027Cash runway, related-party payments
Half-year report to 30 Sep 2026Dec 2026Going-concern language
Magnetite strategic partnerUnscheduledAny MOU or term sheet led by Nigel Jones
Board refreshUnscheduledAppointment of an independent director or chair
ELA 77/3186 decision; national park boundariesUnscheduledTreppo Grande viability
Tenure renewalsAhead of 1 Jul 2028 expiriesM30/206, 207, 228, 229
First hematite sale (royalty trigger)Not before 2027 (analyst view)A$5M milestone at 1 Mt dmt

Concluding Analyst Verdict

Macarthur Minerals is no longer the iron ore developer its boilerplate describes. It is an option-holder with a near-empty treasury. Its economic value now rests on three things it does not control: whether a private operator group (Gold Valley Yilgarn and Destec) can commercialise low-grade Yilgarn hematite; whether a well-funded strategic party will back a marginal 3 Mtpa magnetite project; and whether equity markets will keep funding a corporate overhead of roughly A$1.5–2M a year.

The asset base is genuine. The company holds a 236.6 Mt reserve with a completed Feasibility Study, granted mining leases, environmental approvals, infrastructure licences and fresh Program of Work approvals. Book equity of about A$52M against a market value of about A$7M shows how heavily the market discounts both recoverability and execution. The 2024 hematite transaction was defensible from a liquidity standpoint, but it crystallised a A$22M write-down, and its royalty timetable has already slipped past the FY2025/26 window the board itself flagged.

Destec's arrival in 2026, as both a shareholder and a 50% holder of the hematite agreement, is the most constructive development in years. It brings operating capability that Macarthur lacks. Recent on-market director buying, though small, is consistent with that view.

Against this, governance is thin. The Chair and CEO roles are combined, there is no confirmed independent director, board meetings are infrequent, related-party loans recur, and an ASX disclosure query and an auditor resignation both landed in April 2026. Liquidity is the binding constraint. The June 2026 cash balance of A$324K points to another dilutive raise within months.

Verdict: a high-risk, binary, speculative exposure. Absent a royalty event or a named magnetite partner, the base case is further share-count expansion at depressed prices. Key evidence to watch: bulk-sampling execution and the terms of the next capital raising.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameRoleAppointedBackgroundTotal remuneration

Cameron McCall

Executive Chairman and CEO

Board 27 Apr 2015; CEO Sep 2022

Over 40 years in financial services and commercial property; more than 18 years at Hartleys and Macquarie Bank in equity capital markets and broking; runs a corporate advisory business. Former Infinity Mining director (Feb 2018–Aug 2024).

FY2025: A$354,425 (A$300,000 salary + A$54,425 equity). FY2024: A$387,560. FY2023: A$740K per Simply Wall St.

Alan (Spence) Phillips

Non-Executive Director; Audit and Risk Committee member

19 Oct 2005

40 years as executive, director or chair of ASX, TSXV, TSX and AIM companies; start-ups and turnarounds in copper, gold, ethanol, iron ore and technology. Re-elected at the 2026 AGM.

FY2025: A$141,469 (A$95,000 fees + A$46,469 equity)

Nigel Jones

Non-Executive Director

—

Former Managing Director of Rio Tinto's Simandou iron-ore project; engaged to pursue strategic transactions for the magnetite project

Not publicly disclosed in material reviewed

Mima Wirakara

Company Secretary

—

15 years in company secretarial and governance roles for ASX, TSX and POMSoX resource companies

—

Ian McCall

CFO (per Kalkine). A TipRanks item refers to a one-off equity bonus of 656,757 shares to a "former CFO, Mr McCall".

—

Not disclosed; family relationship to the Chairman not confirmed in filings reviewed

—

Earl Evans

Consultant (per Kalkine)

———

“—” = not publicly disclosed.

Major Shareholders

HolderSharesOptionsRestricted share units (hurdle: A$0.20 for 20 days, expire 24 Jan 2027)

C McCall

3,665,821 direct + 14,000 indirect

1,900,000700,000

A Phillips

3,414,268 indirect

1,848,100600,000

R Welker

02,300,000600,000

Major Shareholders — Copulos Group

HolderStakeSource / date

Copulos Group

31,972,435 shares, 16.01% at the date of the Form 604 used by InvestSMART

Form 604, 29 Apr 2026. The percentage base appears to predate the 2026 placement; discrepancy noted.

Directors (combined)

Low single-digit %

Appendix 3Y notices

Competitive Landscape

Key Competitors

CompetitorSegment / assetRelative positioning vs Macarthur

Mineral Resources (ASX: MIN)

Former Yilgarn hematite operations (Koolyanobbing hub, Esperance exports)

Major diversified miner; incumbent user of Esperance logistics

Fenix Resources (ASX: FEX)

Mid-West hematite producer with integrated haulage and port

Proves the small-scale hematite model Macarthur outsourced to GVY

Mount Gibson Iron (ASX: MGX)

Hematite producer (Koolan Island)

Producing; net cash; competes for buyers

Grange Resources (ASX: GRR)

Tasmanian magnetite and pellet producer (Savage River)

The only established Australian magnetite pellet producer; benchmark for the magnetite model

Magnetite Mines (ASX: MGT)

Razorback magnetite project, South Australia

Peer magnetite developer seeking strategic funding

Hawsons Iron (ASX: HIO)

Hawsons magnetite project, NSW

Peer magnetite developer, also capital-constrained

CZR Resources (ASX: CZR)

Robe Mesa hematite, Pilbara

Junior hematite developer

Champion Iron (TSX/ASX: CIA)

High-grade concentrate producer, Quebec

Global high-grade/DR-grade competitor

Cleveland-Cliffs / LKAB (global)

High-grade pellets and DR feed

Set the "green iron" quality benchmark

Gold Valley group and other private Yilgarn operators

Small-scale DSO operators

Partner today, but also a competitor for tenure

Peer Comparison FY2026

AttributeMacarthur (MIO)Grange ResourcesMagnetite MinesFenix Resources

Stage

Feasibility (magnetite); royalty (hematite)

Producer

Pre-development

Producer

Product grade

66% Fe concentrate (study)

Pellets / concentrate

High-grade concentrate (study)

DSO hematite

Initial capex need

A$863M

Sustaining only

—

Low

Balance sheet

Cash A$0.3M (Jun 2026)

———

Recent Developments

--

Company Snapshot

2

Employees

2002

Founded

from May, Australia

Headquarters

SWOT Analysis

Strengths

  • Reserve-backed scale. 236.6 Mt Proven and Probable magnetite reserve supporting a 25-year, 3 Mtpa operation (FS, 11 Apr 2022).
  • Large resource upside. 1,269.6 Mt total magnetite resource, with 997 Mt Inferred available for conversion (Aug 2020).
  • Premium product. 66.1–66.2% Fe concentrate with low phosphorus (0.02%) and alumina (0.1%), well suited to DR and pellet feed.
  • Permitted hematite. Ularring holds state and federal environmental approvals, and two PoW approvals were granted in 2026 (Apr and Sep).
  • Capital-free royalty exposure. Up to A$10M in milestone payments plus A$1/dmt, with the operator carrying all costs (Hematite Agreement).
  • Secure tenure. 15 granted mining leases expiring between 2028 and 2034, plus haul-road and borefield licences up to 2045 (tenement schedule, Jun 2026).

Weaknesses

  • Acute illiquidity. Cash of A$324K at 30 Jun 2026; A$784 at 31 Mar 2025.
  • Going-concern qualification in both FY2025 and FY2026.
  • Marginal magnetite economics. Post-tax IRR 10.1%; post-tax NPV6 A$443M against A$863M initial capital.
  • Metallurgy and cost. Plant recovery of 31% and strip ratio of 2.64 imply high costs per tonne of concentrate.
  • Governance concentration. Combined Chair/CEO, no confirmed independent director after October 2025, and only two board meetings in FY2025.
  • Value destruction record. Accumulated losses of A$90.2M at FY2025, and a A$21.99M loss on the hematite sale.

Opportunities

  • Royalty trigger. First hematite shipments by GVY/Destec would unlock A$5M, about 70% of current market cap.
  • Strategic magnetite partner. Nigel Jones's network could attract steelmaker or trader equity.
  • Green-iron premium. Rising premiums for high-grade concentrate and DRI could lift the Feasibility Study NPV.
  • Nickel and cobalt optionality. Historical intercepts include 23.5 m @ 0.85% Ni and grab samples to 2.61% Co, with seven untested targets.
  • Hematite-magnetite blending. Bulk sampling may show blended products that improve hematite value.
  • Discount to book. Market cap of about A$7M against equity of about A$52M offers rerating potential if capitalised costs prove recoverable.

Threats

  • Counterparty execution risk. The royalty depends on private operators. The FY2025 AR expected royalties in FY2025/26, and none were reported.
  • Dilution. Shares on issue rose by roughly 60–80% between FY2025 and 2026 (rights issue plus placement), and further raises look necessary.
  • Port and rail capacity. Esperance capacity is "not certain" (FY2025 AR).
  • National park overlap. Treppo Grande lies within the proposed Helena and Aurora Range National Park; E77/2521 was refused in 2022.
  • Iron ore price and supply. New high-grade supply, notably Simandou, competes directly in the premium segment.
  • Tenure expiry. Leases M30/206, 207, 228 and 229 expire on 1 July 2028 and will need renewal.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
1 May 2025Registered office moves to Waterfront Place, BrisbaneAdministrative
13 May 2025A$250K convertible-note funds received from a major shareholderEmergency liquidity; cash had been A$784 at 31 Mar 2025
16 May 2025Voluntary delisting from TSXV and OTCCuts dual-listing costs; narrows the investor base to Australia
20 May 2025Convertible-note agreement signed: 12-month term, 10% prepaid interest, conversion at A$0.015Dilutive bridge finance
23 May 20251-for-2 renounceable rights issue at A$0.02 announced, with 1 option (A$0.03, 2 years) for every 2 new shares; underwritten by GVYMain FY2026 recapitalisation
23 Jun–9 Jul 2025Rights issue offer periodClosed; about A$1.996M raised (Sep-2025 quarterly)
27 Jun 2025FY2025 Annual Report: net loss A$26.53M; going-concern uncertaintyHematite sale write-down crystallised
11 Jul 2025Deadline for Canadian holders to transfer to the Australian registerCompletes Canadian exit
29 Aug 20252025 AGM; director fee-in-shares plans approvedPreserves cash
Sep-2025 quarterBoard change: new NED (Nigel Jones)Adds iron-ore development experience
6 Oct 2025Ryan Welker ceases as directorLoss of the last confirmed independent director
31 Oct 2025Sep-2025 quarterly: operating outflow A$1.76M; cash A$315K; 0.18 quarters of fundingLiquidity stress flagged
Q3 FY2026Non-iron-ore sampling program at Lake GilesDiversification test
11 Dec 2025Half-yearly report to 30 Sep 2025Routine
30 Jan 2026Dec-2025 quarterly and Appendix 5BRoutine
27 Mar 2026Pause in trading, then trading haltPending capital raising
27 Mar 2026Cessation of securities notice; Phillips Appendix 3YOptions or RSUs lapse
31 Mar 2026Firm commitments received for placementA$1.25M raise
2 Apr 2026PoW approval received for M30/249 and M30/213Enables bulk sampling
8 Apr 2026Placement completed: 50M shares at A$0.025 plus 25M options (A$0.05, expire 7 Oct 2027); Destec becomes a substantial shareholderStrategic investor on the register
9 Apr 2026PoW approval announcedMarket-moving; share price −3.3% on the day
16 Apr 2026Response to ASX query on timing of the cleansing notice versus PoW disclosure; Form 604 for Gold ValleyContinuous-disclosure scrutiny; no breach conceded
20 Apr 2026Change of auditor announced (RSM resigns; William Buck appointed effective 24 Apr)Governance; no disagreements reported
29 Apr 2026Mar-2026 quarterly: cash A$799K. Form 604 for Copulos Group (16.01%).Liquidity briefly improved
4 Jun 2026Consent to the GVY–Destec joint-venture arrangementStrengthens the hematite operator group
17 Jun 20263,333,333 shares issued on final convertible-note conversionNotes fully extinguished
29 Jun 2026FY2026 Annual Report: net loss A$1.82M; cash A$796K; going-concern uncertaintyLoss sharply narrower
13–14 Jul 2026Directors McCall and Phillips buy shares on marketInsider buying signal
29 Jul 202612.1M placement options (A$0.10) expire unexercised (expiry date per FY2025 AR)Out of the money
30 Jul 2026Jun-2026 quarterly: cash A$324K; no material drillingRenewed funding pressure
31 Aug 20262026 AGM: Phillips and McCall re-elected; Nigel Jones elected; William Buck appointed auditorGovernance continuity
3 Sep 2026Additional PoW for Central region hematite bulk samplingSecond regulatory approval; sampling areas identified with Destec

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

3 charts
Revenue by Segment: Exploration segment revenue and other income fell from AUD 9.2 Mn in FY2022 to AUD 0 Mn in FY2026.
Macarthur Minerals Limited — Revenue by Segment
Series (AUD Mn)FY2022FY2023FY2024FY2025FY2026
Exploration segment revenue and other income9.20.90.300
Exploration segment pre-tax result4.5-4.9-5.8-26.5-1.8

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. Macarthur Minerals Annual Report, year ended 31 March 2025 (ASX, 27 Jun 2025) (announcements.asx.com.au)
  2. Quarterly Activities Report, period ended 30 June 2026 (30 Jul 2026) (investorpa.com)
  3. Quarterly Activities Report and Appendix 5B, period ended 31 March 2026 (29 Apr 2026), via InvestSMART summaries and Webull bulletin
  4. Quarterly Activities Report and Appendix 5B, period ended 30 September 2025 (31 Oct 2025), via InvestSMART summaries
  5. Additional PoW approval for bulk sampling (3 Sep 2026) (investorpa.com)
  6. Results of 2025 AGM (29 Aug 2025) and 2026 AGM (31 Aug 2026): ASX announcements
  7. Response to ASX Query (16 Apr 2026); GVY–Destec JV consent (4 Jun 2026): InvestSMART summaries
  8. FY2022 and FY2023 Annual Reports (ASX, 30 Jun 2022 and 28 Jun 2023), cover and summary pages
  9. FilingReader, "Macarthur Minerals narrows annual loss to $1.8m" (29 Jun 2026)
  10. Kalkine Media company page (FY2026 balance sheet, market cap, executives)
  11. StockAnalysis (ASX:MIO profile); Simply Wall St (management and compensation); TipRanks (income statement history, director notices)
  12. InvestSMART announcements list and substantial holders (Copulos Group 16.01%)
  13. Morningstar Australia company profile (employees: 2)
  14. GlobeNewswire, "Macarthur Minerals ASX Listing Completed" (10 Dec 2019); Shaw and Partners (16 Oct 2019); Small Caps; Mining News; Mining Weekly (11 Jun 2021)
  15. Newswire.ca, "Macarthur Minerals Closed Private Placement" (29 Jul 2024)
  16. FinNews Network, nine-month results to 31 Dec 2024 (14 Feb 2025)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.